A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

NCT05840952 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: ALG-097558
DRUG: Placebo
DRUG: Midazolam
DRUG: Itraconazole
DRUG: Carbamazepine
DRUG: ALG-097558 in solution formulation
DRUG: ALG-097558 in tablet formulation

Sponsor

Aligos Therapeutics